A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaAnders Kristoffersson, Elisabet I. Nielsen, Isabelle Walter et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 18
1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017Rusudan Okujava, Kenneth A. Bradley, Fernando García-Alcalde et al.|Open Forum Infectious Diseases|2018Cited by 13